Found: 13
Select item for more details and to access through your institution.
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 5, p. 717, doi. 10.1038/s41587-022-01540-7
- By:
- Publication type:
- Article
Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 10, p. 1137, doi. 10.1038/s41587-019-0227-7
- By:
- Publication type:
- Article
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 3, p. 252, doi. 10.1038/s41587-019-0016-3
- By:
- Publication type:
- Article
Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients.
- Published in:
- Hypertension Research, 2010, v. 33, n. 8, p. 790, doi. 10.1038/hr.2010.85
- By:
- Publication type:
- Article
Candesartan effect on inflammation in hypertension.
- Published in:
- Hypertension Research, 2010, v. 33, n. 3, p. 209, doi. 10.1038/hr.2009.212
- By:
- Publication type:
- Article
Blood Pressure Control and Inflammatory Markers in Type 2 Diabetic Patients Treated with Pioglitazone or Rosiglitazone and Metformin.
- Published in:
- Hypertension Research, 2007, v. 30, n. 5, p. 387, doi. 10.1291/hypres.30.387
- By:
- Publication type:
- Article
Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-α.
- Published in:
- Hypertension Research, 2006, v. 29, n. 11, p. 849, doi. 10.1291/hypres.29.849
- By:
- Publication type:
- Article
Synergistic Effect of Doxazosin and Acarbose in Improving Metabolic Control in Patients with Impaired Glucose Tolerance.
- Published in:
- Clinical Drug Investigation, 2006, v. 26, n. 9, p. 529, doi. 10.2165/00044011-200626090-00006
- By:
- Publication type:
- Article
Matrix Metalloproteinase-2, -9 and Tissue Inhibitor Metalloproteinase-1 in Patients with Hypertension Before and After Doxazosin Therapy.
- Published in:
- High Blood Pressure & Cardiovascular Prevention, 2006, v. 13, n. 3, p. 47, doi. 10.2165/00151642-200613020-00002
- By:
- Publication type:
- Article
Matrix Metalloproteinase-2, -9 and Tissue Inhibitor Metalloproteinase-1 in Patients with Hypertension Before and After Doxazosin Therapy.
- Published in:
- High Blood Pressure & Cardiovascular Prevention, 2006, v. 13, n. 2, p. 47, doi. 10.2165/00151642-200613020-00002
- By:
- Publication type:
- Article
Oral fat load effects on inflammation and endothelial stress markers in healthy subjects.
- Published in:
- Heart & Vessels, 2009, v. 24, n. 3, p. 204, doi. 10.1007/s00380-008-1109-y
- By:
- Publication type:
- Article
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia.
- Published in:
- Clinical & Investigative Medicine, 2009, v. 32, n. 2, p. E124, doi. 10.25011/cim.v32i2.6030
- By:
- Publication type:
- Article